The COMCID Study Raises New Questions in Dementia Research
National Cerebral and Cardiovascular Center
The COMCID study is Japan’s first multicenter investigator-initiated clinical trial involving patients with mild cognitive impairment
Researchers are finding clues that may help treat rare and deadly diseases using mini-organs and advanced technology
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements